Liver Cancer Global Clinical Trials Review, H2, 2012

195 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
195
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Liver Cancer Global Clinical Trials Review, H2, 2012

  1. 1. Liver Cancer Global Clinical Trials Review, H2, 2012Report Details:Published:December 2012No. of Pages: 159Price: Single User License – US$2500Liver Cancer Global Clinical Trials Review, H2, 2012SummaryGlobalDatas clinical trial report, “Liver Cancer Global Clinical Trials Review, H2, 2012" providesdata on the Liver Cancer clinical trial scenario. This report provides elemental information and datarelating to the clinical trials on Liver Cancer. It includes an overview of the trial numbers and theirrecruitment status as per the site of trial conduction across the globe. The databook offers apreliminary coverage of disease clinical trials by their phase, trial status, prominence of thesponsors and also provides briefing pertaining to the number of trials for the key drugs for treatingLiver Cancer. This report is built using data and information sourced from proprietary databases,primary and secondary research and in-house analysis by GlobalDatas team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability andrelevance of data for the indicated disease.Scope- Data on the number of clinical trials conducted in North America, South and Central America,Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, alongwith the clinical trial scenario in BRIC nations- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited andsponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)Reasons to buy- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location,sponsor type and many more- Obtain discontinued trial listing for trials across the globe
  2. 2. - Espy the commercial landscape of the major Universities / Institutes / Hospitals or CompaniesGet your copy of this report @http://www.reportsnreports.com/reports/210600-liver-cancer-global-clinical-trials-review-h2-2012.htmlMajor points covered in Table of Contents of this report includeTable of ContentsTable of Contents 2List of Tables 5List of Figures 6Introduction 7Liver Cancer 7Report Guidance 7Clinical Trials by Region 8Clinical Trials by Country 9Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11Top Five Countries Contributing to Clinical Trials in Europe 12Top Five Countries Contributing to Clinical Trials in North America 13Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14Top Five Countries Contributing to Clinical Trials in Central and South America 15Clinical Trials by BRIC Nations 16Clinical Trials by G7 Nations 17Clinical Trials in G7 Nations by Trial Status 18Clinical Trials by E7 Nations 19Clinical Trials in E7 Nations by Trial Status 20Clinical Trials by Phase 21In Progress Trials by Phase 22Clinical Trials by Trial Status 23Unaccomplished Trials of Liver Cancer 24Subjects Recruited Over a Period of Time 36Prominent Sponsors 37Top Companies Participating in Liver Cancer Therapeutics Clinical Trials 39Prominent Drug Comparison 41Clinical Trial Profiles 42Clinical Trial Overview of Top Companies 42Bayer AG 42Clinical Trial Overview of Bayer AG 42Bristol-Myers Squibb Company 44Clinical Trial Overview of Bristol-Myers Squibb Company 44Pfizer Inc. 45Clinical Trial Overview of Pfizer Inc. 45Taiho Pharmaceutical Co., Ltd. 46Clinical Trial Overview of Taiho Pharmaceutical Co., Ltd. 46
  3. 3. Sanofi 47Clinical Trial Overview of Sanofi 47Novartis AG 48Clinical Trial Overview of Novartis AG 48Celsion Corporation 49Clinical Trial Overview of Celsion Corporation 49Pathfinder Therapeutics, Inc. 50Clinical Trial Overview of Pathfinder Therapeutics, Inc. 50AstraZeneca PLC 51Clinical Trial Overview of AstraZeneca PLC 51Jennerex Biotherapeutics, Inc. 52Clinical Trial Overview of Jennerex Biotherapeutics, Inc. 52GlaxoSmithKline plc 53Clinical Trial Overview of GlaxoSmithKline plc 53Eli Lilly and Company 54Clinical Trial Overview of Eli Lilly and Company 54F. Hoffmann-La Roche Ltd. 55Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 55Merck & Co., Inc. 56Clinical Trial Overview of Merck & Co., Inc. 56Light Sciences Oncology, Inc. 57Clinical Trial Overview of Light Sciences Oncology, Inc. 57Kowa Company, Ltd. 58Clinical Trial Overview of Kowa Company, Ltd. 58ArQule, Inc. 59Clinical Trial Overview of ArQule, Inc. 59BioAlliance Pharma SA 60Clinical Trial Overview of BioAlliance Pharma SA 60Eisai Inc. 61Clinical Trial Overview of Eisai Inc. 61Bio-Cancer Treatment International Limited 62Clinical Trial Overview of Bio-Cancer Treatment International Limited 62Clinical Trial Overview of Top Universities / Institutes / Hospitals 63Eastern Hepatobiliary Surgery Hospital 63Clinical Trial Overview of Eastern Hepatobiliary Surgery Hospital 63The University of Texas M. D. Anderson Cancer Center 66Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 66Sun Yat-sen University 69Clinical Trial Overview of Sun Yat-sen University 69FUDAN University 71Clinical Trial Overview of FUDAN University 71Memorial Sloan Kettering Cancer Center 73
  4. 4. Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 73National Taiwan University Hospital 75Clinical Trial Overview of National Taiwan University Hospital 75Massachusetts General Hospital 76Clinical Trial Overview of Massachusetts General Hospital 76National Cancer Center Hospital 78Clinical Trial Overview of National Cancer Center Hospital 78University of Pittsburgh 79Clinical Trial Overview of University of Pittsburgh 79Stanford University 80Clinical Trial Overview of Stanford University 80Seoul National University Hospital 81Clinical Trial Overview of Seoul National University Hospital 81West China Hospital 82Clinical Trial Overview of West China Hospital 82University Health Network 83Clinical Trial Overview of University Health Network 83Kaohsiung Medical University Chung-Ho Memorial Hospital 84Clinical Trial Overview of Kaohsiung Medical University Chung-Ho Memorial Hospital 84University of Milan 85Clinical Trial Overview of University of Milan 85Roswell Park Cancer Institute 86Clinical Trial Overview of Roswell Park Cancer Institute 86Mayo Clinic 87Clinical Trial Overview of Mayo Clinic 87Kurume University 88Clinical Trial Overview of Kurume University 88Queen Mary Hospital 89Clinical Trial Overview of Queen Mary Hospital 89Kyoto University 90Clinical Trial Overview of Kyoto University 90Five Key Clinical Profiles 91Appendix 156Abbreviations 156Definitions 156Research Methodology 157Secondary Research 157About GlobalData 158Contact Us 158Disclaimer 158Source 159
  5. 5. List of TablesLiver Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2012* 8Liver Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9Liver Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10Liver Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 11Liver Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 12Liver Cancer Therapeutics Clinical Trials, North America, Top Five Countries, 2012* 13Liver Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012* 14Liver Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012*15Liver Cancer Therapeutics Clinical Trials, BRIC Countries, 2012* 16Liver Cancer Therapeutics Clinical Trials, G7 Countries, 2012* 17Liver Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18Liver Cancer Therapeutics Clinical Trials, E7 Countries, 2012* 19Liver Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20Liver Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2012* 21Liver Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 22Liver Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23Liver Cancer Therapeutics Market, Global, Suspended Clinical Trials, 2012* 24Liver Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 26Liver Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2012* 28Liver Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-201136Liver Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 38Liver Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 40Liver Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 41Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2012* 42Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers SquibbCompany, 2012* 44Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 45Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Taiho PharmaceuticalCo., Ltd., 2012* 46Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012* 47Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 48Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Celsion Corporation,2012* 49Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by PathfinderTherapeutics, Inc., 2012* 50Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC,2012* 51Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by JennerexBiotherapeutics, Inc., 2012* 52
  6. 6. Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc,2012* 53Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company,2012* 54Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La RocheLtd., 2012* 55Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc.,2012* 56Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Light SciencesOncology, Inc., 2012* 57Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Kowa Company, Ltd.,2012* 58Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by ArQule, Inc., 2012* 59Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by BioAlliance Pharma SA,2012* 60Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2012* 61Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bio-Cancer TreatmentInternational Limited, 2012* 62Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eastern HepatobiliarySurgery Hospital, 2012* 63Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of TexasM. D. Anderson Cancer Center, 2012* 66Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University,2012* 69Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by FUDAN University,2012* 71Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial SloanKettering Cancer Center, 2012* 73Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National TaiwanUniversity Hospital, 2012* 75Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts GeneralHospital, 2012* 76Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer CenterHospital, 2012* 78Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh,2012* 79Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University,2012* 80Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul NationalUniversity Hospital, 2012* 81Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by West China Hospital,2012* 82
  7. 7. Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University HealthNetwork, 2012* 83Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Kaohsiung MedicalUniversity Chung-Ho Memorial Hospital, 2012* 84Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Milan,2012* 85Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park CancerInstitute, 2012* 86Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012* 87Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Kurume University,2012* 88Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen Mary Hospital,2012* 89Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2012*90List of FiguresLiver Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 8Liver Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9Liver Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10Liver Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 11Liver Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 12Liver Cancer Therapeutics Clinical Trials, North America, Top Five Countries (%), 2012* 13Liver Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012*14Liver Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%),2012* 15Liver Cancer Therapeutics Clinical Trials, BRIC Countries (%), 2012* 16Liver Cancer Therapeutics Clinical Trials, G7 Countries (%), 2012* 17Liver Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18Liver Cancer Therapeutics Clinical Trials, E7 Countries (%), 2012* 19Liver Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20Liver Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 21Liver Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 22Liver Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23Liver Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-201136Liver Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 37Liver Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 39Liver Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 41GlobalData Methodology 157
  8. 8. Contact: sales@reportsandreports.com for more information.

×